<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6981">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05070364</url>
  </required_header>
  <id_info>
    <org_study_id>EIG-LMD-002</org_study_id>
    <nct_id>NCT05070364</nct_id>
  </id_info>
  <brief_title>Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV</brief_title>
  <acronym>LIMT-2</acronym>
  <official_title>Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eiger BioPharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eiger BioPharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Phase 3 LIMT-2 study will evaluate the safety and efficacy of Peginterferon Lambda&#xD;
      treatment for 48 weeks with 24 weeks follow-up compared to no treatment for 12 weeks in&#xD;
      patients chronically infected with HDV. The primary analysis will compare the proportion of&#xD;
      patients with HDV RNA &lt; LLOQ at the 24-week post-treatment visit in the Peginterferon Lambda&#xD;
      treatment group vs the proportion of patients with HDV RNA &lt; LLOQ at the Week 12 visit in the&#xD;
      no-treatment comparator group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, open-label, parallel arm study that will allocate patients (2:1) with&#xD;
      chronic HDV infection to one of two treatment groups: Peginterferon Lambda 180 mcg QW for 48&#xD;
      weeks with 24 weeks follow-up (Arm 1, n=100), or no treatment for 12 weeks followed by&#xD;
      Peginterferon Lambda treatment for 48 weeks with 24 weeks of follow-up (Arm 2, n=50). All&#xD;
      patients will receive concomitant therapy with a potent 2nd generation anti-HBV nucleos(t)ide&#xD;
      analogue (NUC) throughout the study duration.&#xD;
&#xD;
      Data collected during Peginterferon Lambda treatment in Arm 2 will not be included in the&#xD;
      primary analysis. The primary purpose of Arm 2 is to provide benchmark data in a parallel&#xD;
      reference group for the expected rate of HDV RNA suppression among patients with chronic HDV&#xD;
      infection who receive 12 weeks of anti-HBV NUC therapy alone.&#xD;
&#xD;
      Prior to randomization, all patients will enter a run-in phase with 12 weeks of anti-HBV NUC&#xD;
      therapy, which will ensure virologic control of HBV (&lt; 100 IU/mL) prior to randomization and&#xD;
      start of Peginterferon Lambda therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 15, 2021</start_date>
  <completion_date type="Anticipated">January 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Durable Virologic Response</measure>
    <time_frame>72 weeks</time_frame>
    <description>HDV RNA below the limit of quantitation at 24 weeks post-treatment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hepatitis Delta Virus</condition>
  <arm_group>
    <arm_group_label>Peginterferon Lambda for 48 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peginterferon Lambda 180 mcg once weekly for 48 weeks with 24 weeks follow-up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment for 12 weeks</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No treatment for 12 weeks followed by Peginterferon Lambda 180 mcg once weekly for 48 weeks and 24 weeks follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Peginterferon Lambda-1a</intervention_name>
    <description>Immunomodulator</description>
    <arm_group_label>Peginterferon Lambda for 48 weeks</arm_group_label>
    <other_name>Lambda</other_name>
    <other_name>Peginterferon Lambda</other_name>
    <other_name>Pegylated Interferon Lambda</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic HDV infection documented by a positive HDV antibody test or a positive HDV RNA&#xD;
             by RT PCR test for at least 6 months prior to Screening&#xD;
&#xD;
          -  Quantifiable HDV RNA by RT-PCR test at Screening&#xD;
&#xD;
          -  Documented confirmed suppression of HBV DNA (&lt; 100 IU/mL) following at least 12 weeks&#xD;
             of anti-HBV NUC treatment with ETV or a TNF-based NUC (TDF or TAF)&#xD;
&#xD;
          -  Serum ALT &gt; upper limit of normal (ULN) and &lt; 10 × ULN.&#xD;
&#xD;
          -  Patients categorized with Child-Turcotte-Pugh score of ≤ 5 with well compensated liver&#xD;
             disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History or current evidence of decompensated liver disease (episodes of variceal&#xD;
             bleeding, ascites or encephalopathy)&#xD;
&#xD;
          -  Treatment with interferons (IFNs) or immunomodulators within 12 months of&#xD;
             randomization or refractory to prior IFN treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole Ramza, MBA</last_name>
    <phone>650-272-6138</phone>
    <email>LIMT-2@eigerbio.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monica Gangal, MSc</last_name>
    <phone>650-272-6138</phone>
    <email>LIMT-2@eigerbio.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asia Pacific Liver Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90020</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Mimi Chang</last_name>
      <phone>213-207-5793</phone>
      <email>mimi.chang@cimtoday.org</email>
    </contact>
    <investigator>
      <last_name>Ho Bae, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Melissa Ramos</last_name>
      <phone>323-442-7983</phone>
      <email>Melissa.Ramos@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Norah Terrault, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Bonnie Chan</last_name>
      <email>chanbw@sutterhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Stewart Cooper, Dr.</last_name>
      <phone>415-600-5878</phone>
      <email>stewartcooper@ielbio.org</email>
    </contact_backup>
    <investigator>
      <last_name>Stewart Cooper, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Diana Goldman</last_name>
      <phone>312-942-8910</phone>
      <email>Diana_Goldman@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy Reau, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Meredith Lewis</last_name>
      <phone>212-824-7931</phone>
      <email>meredith.lewis@mssm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Clara Rodriguez Rivas</last_name>
      <phone>347-920-1830</phone>
      <email>Clara.RodriguezRivas@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>Douglas Dieterich, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>C.H.U. Brugmann</name>
      <address>
        <city>Bruxelles</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Daphné Benteyn</last_name>
      <phone>+3224773621</phone>
      <email>adeline.derodezbenavent@chu-brugmann.be</email>
    </contact>
    <contact_backup>
      <last_name>Adeline De Rodez Benavent</last_name>
      <phone>+32479389738</phone>
      <email>adeline.derodezbenavent@chu-brugmann.be</email>
    </contact_backup>
    <investigator>
      <last_name>Luc Lasser, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires de Bruxelles Hopital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Nesrine Amari</last_name>
      <phone>+32498648167</phone>
      <email>kristof.lesneuck@sgs.com</email>
    </contact>
    <contact_backup>
      <last_name>Smits Françoise</last_name>
      <phone>+32 2 555 4478</phone>
      <email>Francoise.Smits@erasme.ulb.ac.be</email>
    </contact_backup>
    <investigator>
      <last_name>Christophe Moreno, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Antwerp</name>
      <address>
        <city>Edegem</city>
        <zip>B-2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Lotte Schoenmakers</last_name>
      <phone>+ 32 3 821 52 10</phone>
      <email>Lotte.Schoenmakers@uza.be</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Vanwolleghem</last_name>
      <phone>328213853</phone>
      <email>thomas.vanwolleghem@uza.be</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Vanwolleghem, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Karen Roles</last_name>
      <phone>+32 9 332 03 33</phone>
      <email>karen.roels@uzgent.be</email>
    </contact>
    <contact_backup>
      <last_name>Helena Degroote, Dr.</last_name>
      <phone>3293322371</phone>
      <email>helena.degroote@uzgent.be</email>
    </contact_backup>
    <investigator>
      <last_name>Helena Degroote, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Acibadem City Clinic Tokuda Hospital Ead</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <contact>
      <last_name>Marieta Gamzova-Kelleva</last_name>
      <phone>(359) 884-9331 x98</phone>
      <email>marieta.gamzova@acibademcityclinic.bg</email>
    </contact>
    <investigator>
      <last_name>Rozalina Balabanska, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center &quot;Nov Rehabilitatsionen Tsentar&quot;, EOOD</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniela Radicheva</last_name>
      <phone>359887095903</phone>
      <email>d_radicheva@abv.bg</email>
    </contact>
    <contact_backup>
      <last_name>Mariana Penkova, AProf.</last_name>
      <phone>00359888303318</phone>
      <email>mpenkovadoc@abv.bg</email>
    </contact_backup>
    <investigator>
      <last_name>Mariana Penkova, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHP, Hospital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nathalie Ganne, Dr.</last_name>
      <phone>33148026296</phone>
      <email>nathalie.ganne@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie Ganne, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Stephanie Narguet</last_name>
      <phone>+331 40 87 53 81</phone>
      <email>stephanie.narguet@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Tarik Asselah, Dr.</last_name>
      <phone>+33(0)140875579</phone>
      <email>tarik.asselah@bjn.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Tarik Asselah, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Sophie Metivier, Dr.</last_name>
      <phone>+33 5 61 32 34 32</phone>
      <email>metivier.s@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie Metivier, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZIM 1, Gastroenterologie, University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Christine Bott</last_name>
      <phone>+49 69 6301 87687</phone>
      <email>bott@em.uni-frankfurt.de</email>
    </contact>
    <contact_backup>
      <last_name>Kathrin Andrea Sprinzl, Dr.</last_name>
      <phone>0049-69-630187769</phone>
      <email>kathrin.sprinzl@kgu.de</email>
    </contact_backup>
    <investigator>
      <last_name>Kathrin Andrea Sprinzl, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hanover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Olga Stoll</last_name>
      <phone>+49 511 532 83742</phone>
      <email>stoll.olga@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Heiner Wedemeyer, Dr.</last_name>
      <phone>+49 511 532 3306</phone>
      <email>wedemeyer.heiner@mh-hannover.de</email>
    </contact_backup>
    <investigator>
      <last_name>Heiner Wedemeyer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mainz, I. Med. Klinik</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Susan Depoix</last_name>
      <phone>+49 (0) 6131 17 6831</phone>
      <email>susan.depoix@unimedizin-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Annette Grambihler, Dr.</last_name>
      <phone>+49-6131-176831</phone>
      <email>annette.grambihler@unimedizin-mainz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Annette Grambihler, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer-Sheva</city>
        <zip>84001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Tamar Gibor</last_name>
      <phone>972-8-6403589</phone>
      <email>TamarGib@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Ohad Etzion, Dr.</last_name>
      <phone>+972-8-6403330</phone>
      <email>ohadet@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ohad Etzion, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Center</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Vered Ben-Hakoun</last_name>
      <phone>+97248542017</phone>
      <email>v_ben-hakoon@rambam.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Ella Veitsman, Dr.</last_name>
      <phone>+97247772956</phone>
      <email>e_veitsman@rambam.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ella Veitsman, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah University Hospital - Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Yasmin Malabi</last_name>
      <phone>(972) 526-3522 x87</phone>
      <email>yasminm@hadassah.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Rifaat Safadi, Dr.</last_name>
      <phone>+972-2-6777337</phone>
      <email>Safadi@hadassah.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Rifaat Safadi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52363</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Dana Silverberg</last_name>
      <phone>972-3-5307179</phone>
      <email>Dana.Silverberg@sheba.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Ziv Ben Ari, Dr.</last_name>
      <phone>97235307177</phone>
      <email>ziv.ben-ari@sheba.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ziv Ben Ari, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale Casa Sollievo della Sofferenza</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <state>Foggia</state>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Lazzaro Biancofiore</last_name>
      <phone>+39 3297952108</phone>
      <email>lazzarobiancofiore@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Anna Grazia Niro, Dr.</last_name>
      <phone>0882 410274-368 7331028</phone>
      <email>g.niro@operapadrepio.it</email>
    </contact_backup>
    <investigator>
      <last_name>Anna Grazia Niro, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia</name>
      <address>
        <city>Foggia</city>
        <zip>71100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Teresa Antonia Santantonio, Dr.</last_name>
      <phone>+39 0881 732216</phone>
      <email>teresa.santantonio@unifg.it</email>
    </contact>
    <investigator>
      <last_name>Teresa Antonia Santantonio, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Roberta Soffredini</last_name>
      <phone>+39 02 55032216</phone>
      <email>rsoffredini@libero.it</email>
    </contact>
    <contact_backup>
      <last_name>Pietro Lampertico, Dr.</last_name>
      <phone>+390255035432</phone>
      <email>pietro.lampertico@unimi.it</email>
    </contact_backup>
    <investigator>
      <last_name>Pietro Lampertico, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ISMP Spitalul Clinic Republican &quot;Timofei Mosneaga&quot;</name>
      <address>
        <city>Chisinau</city>
        <zip>2025</zip>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Veronica Cumpata</last_name>
      <phone>+373 69353776</phone>
      <email>veronica.cumpataciorba@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Adela Turcanu, Dr.</last_name>
      <phone>+37379682161</phone>
      <email>adela_turcanu@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Adela Turcanu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundeni Clinical Institute</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Elena Laura Iliescu, Dr.</last_name>
      <phone>40722235695</phone>
      <email>laura_ate@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Elena Laura Iliescu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul National de Boli Infectioase &quot;Prof. Dr. Matei Bals&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>021105</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Monica Radu</last_name>
      <phone>40722597702</phone>
      <email>drmnradu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Florin Alexandru Caruntu, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundatia &quot;Dr. Victor Babes&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>030303</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>George Sebastian Gherlan, Dr.</last_name>
      <phone>+40751107879</phone>
      <email>gherlanus@gmail.com</email>
    </contact>
    <investigator>
      <last_name>George Sebastian Gherlan, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Infectios Diseases Hospital</name>
      <address>
        <city>Constanta</city>
        <zip>900709</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Roxana Cernat</last_name>
      <phone>0040(723364468)</phone>
      <email>roxana.cernat@seanet.ro</email>
    </contact>
    <contact_backup>
      <last_name>Irina Magdalena Dumitru, Dr.</last_name>
      <phone>+40744761297</phone>
      <email>dumitrui@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Irina Magdalena Dumitru, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul de Infectioase Galati Romania</name>
      <address>
        <city>Galati</city>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <last_name>Liliana Baroiu, Dr.</last_name>
      <phone>40723201241</phone>
      <email>lilibaroiu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Liliana Baroiu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>State budgetary institution of health care &quot;Specialized clinical infectious diseases hospital&quot; of the Ministry of health of Krasnodar region</name>
      <address>
        <city>Krasnodar</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Victoria Bakhtina, Dr.</last_name>
      <phone>8(861)255-29-97</phone>
      <email>dom-167@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Victoria Bakhtina, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Modern Medicine Clinic, LLC</name>
      <address>
        <city>Moscow</city>
        <zip>121170</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Tatiana Stepanova, Dr.</last_name>
      <phone>79067937122</phone>
      <email>tvstepa@list.ru</email>
    </contact>
    <investigator>
      <last_name>Tatiana Stepanova, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H-Clinic, LLC</name>
      <address>
        <city>Moscow</city>
        <zip>127083</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Natalia Voronkova, Dr.</last_name>
      <phone>79104439528</phone>
      <email>voronkova@h-clinic.ru</email>
    </contact>
    <investigator>
      <last_name>Natalia Voronkova, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center Tagetnoy Terapii, LLC</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Pavel Bogomolov, Dr.</last_name>
      <phone>+7 (925) 504-61-34</phone>
      <email>bpo73@list.ru</email>
    </contact>
    <investigator>
      <last_name>Pavel Bogomolov, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Healthy Family, LLC</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630099</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Natalia Voloshina, Dr.</last_name>
      <phone>+79139351044</phone>
      <email>navo@ngs.ru</email>
    </contact>
    <investigator>
      <last_name>Natalia Voloshina, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hepatolog, LLC</name>
      <address>
        <city>Samara</city>
        <zip>443063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Viacheslav Morozov, Dr.</last_name>
      <phone>+78463004411</phone>
      <email>viacheslavmorozov@yandex.ru</email>
    </contact>
    <investigator>
      <last_name>Viacheslav Morozov, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>State Budgetary Educational Institution of Higher Profesional Education &quot;Stavropol State Medical University&quot; of MoH</name>
      <address>
        <city>Stavropol</city>
        <zip>355017</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <last_name>Natalia Geyvandova, Dr.</last_name>
      <phone>+7-9624452246</phone>
      <email>ngeyvandova@yandex.ru</email>
    </contact>
    <investigator>
      <last_name>Natalia Geyvandova, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Adriana Palom</last_name>
      <phone>0034 93 274 60 00</phone>
      <phone_ext>4066</phone_ext>
      <email>adrianapalom@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Buti, Dr.</last_name>
      <phone>34 93 274 60 00</phone>
      <phone_ext>4066/6562</phone_ext>
      <email>mbuti@vhebron.net</email>
    </contact_backup>
    <investigator>
      <last_name>Maria Buti, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Alcorcón</name>
      <address>
        <city>Madrid</city>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Maria Luisa Gutiérrez García, Dr.</last_name>
      <phone>+34 916219890</phone>
      <email>mlgutierrez@fhalcorcon.es</email>
    </contact>
    <contact_backup>
      <email>marialuisa.gutierrez@salud.madrid.org</email>
    </contact_backup>
    <investigator>
      <last_name>Maria Luisa Gutiérrez García, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istanbul Universitry-Cerrahapasa, Cerrahpasa School of Medicine</name>
      <address>
        <city>Kocamustafapasa</city>
        <state>Cad</state>
        <zip>34096</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Fehmi Tabak, Dr.</last_name>
      <phone>00905322763788</phone>
      <email>ftabak@istanbul.edu.tr</email>
    </contact>
    <contact_backup>
      <email>fehmitabak@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Fehmi Tabak, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dicle University, Medical Faculty</name>
      <address>
        <city>Diyarbakır</city>
        <zip>21280</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Celen Mustafa Kemel, Dr.</last_name>
      <phone>+905336207022</phone>
      <email>mkcelen@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Celen Mustafa Kemel, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Koc University Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Cihan Yurhadin, Dr.</last_name>
      <phone>+90-212-3381000</phone>
      <email>cyurdaydin@ku.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Cihan Yurhadin, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Municipal Non-Profit Enterprise &quot;Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital&quot; of Ivano-Frankivsk Regional Council</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <state>Oblast</state>
        <zip>76000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sumy State University Clinic</name>
      <address>
        <city>Sumy</city>
        <state>Oblast</state>
        <zip>40000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <last_name>Chemych Mykola Dmytrovich, Dr.</last_name>
      <phone>+380506310579</phone>
      <email>chemych@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chemych Mykola Dmytrovich, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center of LLC &quot;Harmoniya Krasy&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>01135</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <last_name>Ihor Anastasii, Dr.</last_name>
      <phone>+38 050 440 53 89</phone>
      <email>ihor.anastasii@arensia-em.com</email>
    </contact>
    <investigator>
      <last_name>Ihor Anastasii, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center 'Ok!Clinic+' of International Institute of Clinical Studies LLC</name>
      <address>
        <city>Kyiv</city>
        <zip>02091</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <last_name>Nataliia Tsarynna, Dr.</last_name>
      <phone>+380937694807</phone>
      <email>nataliia.tsarynna@okclinic.com.ua</email>
    </contact>
    <investigator>
      <last_name>Nataliia Tsarynna, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ternopil University Hospital</name>
      <address>
        <city>Ternopil</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <last_name>Ihor Hospodarskyy, Dr.</last_name>
      <phone>+380673324732</phone>
      <email>gospodar.igor@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ihor Hospodarskyy, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Communal Noncommercial Enterprise Vinnytsia City Clinical Hospital #l, Infectious Department, National Pirogov Memorial Medical University, Vinnytsya , Chair of Infectious Diseases with Course in Epidemiolog</name>
      <address>
        <city>Vinnytsia</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <last_name>Larysa Moroz, Dr.</last_name>
      <phone>+380965363123</phone>
      <email>larisa652002@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Larysa Moroz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Moldova, Republic of</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 27, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2021</study_first_posted>
  <last_update_submitted>December 10, 2021</last_update_submitted>
  <last_update_submitted_qc>December 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HDV</keyword>
  <keyword>Hepatitis D</keyword>
  <keyword>Viral Hepatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis D</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

